Catherine Skari

Splenectomy Significantly Associated with Thrombosis but Not with Pulmonary Hypertension in Patients with Transfusion-Dependent Thalassemia: A Meta-analysis of Observational Studies

Introduction: Thromboembolism (TE) and pulmonary hypertension (PH) constitute frequently occurring complications in patients with transfusion-dependent thalassemia and have been associated…

Read More »

Deferiprone vs Deferoxamine for Transfusional Iron Overload in Sickle Cell Disease and Other Anemias: Pediatric Subgroup Analysis of the Randomized, Open-label FIRST Study

Background: Children with sickle cell disease (SCD) who are chronically transfused often, require iron chelation therapy. There are limited data…

Read More »

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | LDH Improvements Lead to Better Outcomes in Fatigue and QoL

PNH is a rare anaemia known for causing blood cell destruction, which can be shown by LDH levels. The study…

Read More »

TIF’s NEW e-COURSE | Enhance Your Understanding of EU Health Policy

To address this need, the Thalassaemia International Federation (TIF) has launched an e-course titled ‘EU Health Policy Course’, which offers…

Read More »

TIF2023 | 16th International Conference on Thalassaemia & Haemoglobinopathies, November 3-5

The Conference, organized in collaboration with the Federation of Malaysia Thalassaemia Societies, the Malaysia Hematology Society and the Malaysian Association…

Read More »

CLINICAL NEWS | Promising Outcomes Found with Stem Cell Transplant for Fanconi Anemia-related Leukemia, MDS

Two-thirds of patients who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) to treat myelodysplastic syndrome (MDS) or acute myeloid leukemia…

Read More »

Pneumococcal Infections in Children with Sickle Cell Disease Before and After Pneumococcal Conjugate Vaccines

Children with sickle cell disease (SCD) are at increased risk of invasive pneumococcal infections (IPD). Over 25 years the Georgia…

Read More »

POSITION PAPER | Strengthening the Resilience of EU Health Systems

Thalassaemia is more than just a rare condition in Europe; it is a pressing issue that requires prompt action. With…

Read More »

THAL PALS PODCAST | New Episode on TIF’s NTDT Guidelines Out Now

Dr. Κevin Kuo, MD, MSc, Clinician Investigator, and Μrs. Laurice Levine, Thalassaemia Patient Advocate, talk to TIF’s Executive Director, Dr…

Read More »

Imatinib’s Impact on Reducing Painful Episodes in Sickle Cell Disease

Currently, hydroxyurea (HU) is the only FDA-approved drug highly recommended for treating sickle cell anemia. However, its efficiency varies among…

Read More »